CN101401873A - Medicine plaster for treating furunculosis, exogenous injury and rheumatic arthritis - Google Patents
Medicine plaster for treating furunculosis, exogenous injury and rheumatic arthritis Download PDFInfo
- Publication number
- CN101401873A CN101401873A CNA2008102322023A CN200810232202A CN101401873A CN 101401873 A CN101401873 A CN 101401873A CN A2008102322023 A CNA2008102322023 A CN A2008102322023A CN 200810232202 A CN200810232202 A CN 200810232202A CN 101401873 A CN101401873 A CN 101401873A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- plaster
- rhizoma
- furuncle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a plaster for treating furuncle, trauma and rheumatoid arthritis. A black plaster is extracted from carbonized human hair, angelica tails, radix rehmanniae, rhubarb, Baikal skullcap root, multiflower knotweed tuber, Chinese atractylodes, best-quality cinnamon, phellodendron, pangolin, catnip ears, honeysuckle flowers, glossy ganoderma and frankincense sesame oil, is matched with myrrh, croton and radix curcumae, and then is added with borax, hydrargyrum oxydatum crudum and other ingredients so as to prepare the plaster. To furuncle, the plaster has the efficacies of eliminating furuncle surface, removing pus and eliminating symptoms till recovery, regardless of the degree of disease. To rheumatic or rheumatoid symptoms, the plaster can first eliminate obstacles on Qi blood pathways to maintain unobstructed Qi blood circulation, dredges meridians and collaterals through acupuncture points at the same time, regulates Yin-Yang equilibrium of viscera, recovers the physiological functions of human bodies, and fundamentally relieves the pain of patients.
Description
Technical field
The present invention relates to a kind of plaster, more particularly, relate to and a kind ofly treat furuncle, injure the plaster of rheumatic arthritis outward.
Background technology
Furuncle is the acute suppurative inflammation of skin follicle or sebaceous gland, it is one of modal disease among the outer Dou, common Therapeutic Method is to adopt behind the herbal fumigation medication again to wash, and forming pus when serious then needs come evacuation of pus by surgical incision, so can cause very big misery to the patient.And rheumatism, rheumatoid disease are general especially in the crowd, especially middle-aged and elderly people, the traditional Chinese medical science thinks that rheumatism, rheumatoid belong to " arthromyodynia " category: wind, cold, wet three kinds of pathogens mix the intrusion human body, most of because Liver and kidney insufficiency of vital energy and blood, the damp and hot exopathogen invasion and attack of wind and cold cause the resistance of QI and blood numbness obstructed, and lose due to nourish in muscle arteries and veins joint, bring great misery to the patient, simultaneously, also brought very big financial burden simultaneously, individual patient even so and disable to the patient again because the course of disease is long.Common Therapeutic Method nothing more than acupuncture, massage or force on that these are several, so-called acupuncture, massage all belong to the external physical effect, can only play the respite effect, and not from solving question of substance inside; Common plaster also only is to adopt traditional medicine to concoct, and its result also just produces little effect.
Summary of the invention
The objective of the invention is to overcome the defective that exists in the prior art, provide a kind of and can effectively treat furuncle, injure the plaster of rheumatic arthritis outward.
Plaster of the present invention is selected Crinis Carbonisatus, Radix Angelicae Sinensis, the Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Scutellariae, the Radix Polygoni Multiflori, Rhizoma Atractylodis, FANGQI, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Cortex Cinnamomi, Cortex Phellodendri, Squama Manis, Jing Jiesui, Radix Paeoniae Rubra, Flos Lonicerae, Ganoderma, Oleum Sesami of Olibanum, make each efficacy of drugs produce synergism the said medicine formulated in combination, can heat clearing away poison, separate malignant boil, resolving the hard mass, strengthening body resistance and dispelling evil, thus reach therapeutic effect.Wherein select for use Crinis Carbonisatus to be because it has the hemostasis repercussive, the effect of diuresis granulation promoting; Choosing and selecting Radix Angelicae Sinensis is because its energy blood circulation promoting and blood stasis dispelling; Select for use the Radix Rehmanniae to be because it has the effect of clearing away heat and cooling blood; Selecting Radix Et Rhizoma Rhei, Radix Scutellariae for use is that eliminating blood stasis and inducing menstruation has the function of heat-clearing and toxic substances removing because of its energy removing pathogenic heat from blood and toxic substance from the body; Select for use Rhizoma Chuanxiong to be mainly energy blood-activating and qi-promoting, wind-expelling pain-stopping; Selecting the Radix Angelicae Dahuricae for use is because of its energy expelling wind and cold, understand things pain-stopping, detumescence and apocenosis, dampness leukorrhagia stopping; Being elected to be Cortex Phellodendri is because of its energy heat clearing and damp drying, and pathogenic fire purging removes steams, detoxifcation treatment skin ulcer; Selecting Squama Manis for use mainly is to be used for promoting blood circulation to restore menstrual flow, strengthening the tendons and bones, and selecting for use Jing Jiesui, Radix Paeoniae Rubra, Flos Lonicerae can move back cold and heat again can subduing inflammation; The Ganoderma of selecting for use has antineoplastic action.
In order to reach better therapeutic effect, medicine of the present invention is also selected Myrrha, Fructus Crotonis, Radix Curcumae, Realgar combination for use.This is the blood blood stasis removing because Myrrha can loose, subduing swelling and relieving pain; Radix Curcumae has regulating qi to disperse stagnation, the effect of heart fire-clearing upset-relieving.
In order to obtain optimum curative effect, the present invention also adds hydrophite, Borax, hydrargrum oxydatum crudum and carries out compatibility on the said medicine basis, and hydrophite and Borax have heat clearing away, expectorant, detoxifcation, antiseptical effect; Hydrargrum oxydatum crudum has draws out pus by applying a plaster to the affected part, and carries pus, the effect of tissue regeneration promoting.
In addition, medicine of the present invention can also add Rhizoma Arisaematis, Radix Aconiti Kusnezoffii, Fructus Cnidii, the poplar bloassom that makes a noise, Folium Artemisiae Argyi carry out compatibility, to remove QI and blood path obstacle, keeps the QI and blood circulation unobstructed.
Each drug component consumption of the present invention is:
8 parts of Crinis Carbonisatus, 3 parts of Radix Angelicae Sinensis, 3 parts in the Radix Rehmanniae, 1 part of Radix Et Rhizoma Rhei, 1 part of Radix Scutellariae, 1 part of the Radix Polygoni Multiflori, 1 part of Rhizoma Atractylodis, 2 parts of FANGQI, 3 parts of Rhizoma Chuanxiongs, 4 parts of the Radixs Angelicae Dahuricae, 2 parts of Cortex Cinnamomi, 4 parts of Cortex Phellodendris, 3 parts of Squama Manis, 3 parts of Jing Jie fringes, 2 parts of Radix Paeoniae Rubra, 4 parts of Flos Loniceraes, 2 parts of Ganodermas, 10 parts of Oleum Sesami of Olibanum.
Each amounts of components of medicine of the present invention can also be:
8 parts of Crinis Carbonisatus, 3 parts of Radix Angelicae Sinensis, 3 parts in the Radix Rehmanniae, 1 part of Radix Et Rhizoma Rhei, 1 part of Radix Scutellariae, 1 part of the Radix Polygoni Multiflori, 1 part of Rhizoma Atractylodis, 2 parts of FANGQI, 3 parts of Rhizoma Chuanxiongs, 4 parts of the Radixs Angelicae Dahuricae, 2 parts of Cortex Cinnamomi, 4 parts of Cortex Phellodendris, 3 parts of Squama Manis, 3 parts of Jing Jie fringes, 2 parts of Radix Paeoniae Rubra, 4 parts of Flos Loniceraes, 2 parts of Ganodermas, 10 parts of Oleum Sesami of Olibanum, 3 parts of Myrrhas, 3 parts of Fructus Crotonis, 3 parts of Radix Curcumaes, 3 parts of Realgar.
The medicine of the present invention further consumption of each component is:
8 parts of Crinis Carbonisatus, 3 parts of Radix Angelicae Sinensis, 3 parts in the Radix Rehmanniae, 1 part of Radix Et Rhizoma Rhei, 1 part of Radix Scutellariae, 1 part of the Radix Polygoni Multiflori, 1 part of Rhizoma Atractylodis, 2 parts of FANGQI, 3 parts of Rhizoma Chuanxiongs, 4 parts of the Radixs Angelicae Dahuricae, 2 parts of Cortex Cinnamomi, 4 parts of Cortex Phellodendris, 3 parts of Squama Manis, 3 parts of Jing Jie fringes, 2 parts of Radix Paeoniae Rubra, 4 parts of Flos Loniceraes, 2 parts of Ganodermas, 10 parts of Oleum Sesami of Olibanum, 3 parts of Myrrhas, 3 parts of Fructus Crotonis, 3 parts of Radix Curcumaes, 3 parts of Realgar, 4 parts of hydrophites, 4 parts of Borax, 4 parts of hydrargrum oxydatum crudums.
Medicine of the present invention further each component consumption can also for:
8 parts of Crinis Carbonisatus, 3 parts of Radix Angelicae Sinensis, 3 parts in the Radix Rehmanniae, 1 part of Radix Et Rhizoma Rhei, 1 part of Radix Scutellariae, 1 part of the Radix Polygoni Multiflori, 1 part of Rhizoma Atractylodis, 2 parts of FANGQI, 3 parts of Rhizoma Chuanxiongs, 4 parts of the Radixs Angelicae Dahuricae, 2 parts of Cortex Cinnamomi, 4 parts of Cortex Phellodendris, 3 parts of Squama Manis, 3 parts of Jing Jie fringes, 2 parts of Radix Paeoniae Rubra, 4 parts of Flos Loniceraes, 2 parts of Ganodermas, 10 parts of Oleum Sesami of Olibanum, 3 parts of Myrrhas, 3 parts of Fructus Crotonis, 3 parts of Radix Curcumaes, 3 parts of Realgar, 2 parts of hydrophites, 3 parts of Borax, 4 parts of hydrargrum oxydatum crudums, 4 parts of Rhizoma Arisaematis, 4 parts of Radix Aconiti Kusnezoffii, 2 parts of Fructus Cnidiis, 4 parts of the poplar bloassoms that make a noise, 4 parts of Folium Artemisiae Argyis.
The preparation method of medicine of the present invention is as follows:
A) Crinis Carbonisatus, Radix Angelicae Sinensis, the Radix Rehmanniae, Radix Et Rhizoma Rhei, Radix Scutellariae, the Radix Polygoni Multiflori, Rhizoma Atractylodis, FANGQI, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Cortex Cinnamomi, Cortex Phellodendri, Squama Manis, Jing Jiesui, Radix Paeoniae Rubra, Flos Lonicerae, Ganoderma, the Oleum Sesami of Olibanum with described weight proportion refines into the black unguentum;
B) Myrrha, Fructus Crotonis, Radix Curcumae, the Realgar with described weight ratio makes up, and is mixed with a kind of yellow medicament with viscosity, throws on the plaster that posts at the above-mentioned steps stand;
C) hydrophite, Borax, the hydrargrum oxydatum crudum with described weight ratio carries out compatibility, throw on the xanchromatic medicament of second step.
Medicine of the present invention has following effect:
1, to furuncle, the state of an illness is weight no matter, all has the skin ulcer face of removing, dials and remove the pus body, eliminate the effect of symptom to recovery from illness;
2, to rheumatism, rheumatoid disease, at first can remove QI and blood path obstacle, keep the QI and blood circulation unobstructed, simultaneously by the acupuncture point dredging the meridian, meridians are regulated the internal organs equilibrium between yin and yang, recover human physiological functions, have fundamentally removed patient's slight illness.
The specific embodiment
Come by the following examples the preparation method and the beneficial effect of medicine of the present invention are further elaborated.
1, the preparation method of medicine of the present invention and using method
Preparation method
The first step is refined into the black unguentum with Crinis Carbonisatus 100g part, Radix Angelicae Sinensis 25g, Radix Rehmanniae 25g, Radix Et Rhizoma Rhei 10g, Radix Scutellariae 10g, Radix Polygoni Multiflori 10g, Rhizoma Atractylodis 10g, FANGQI 25g, Rhizoma Chuanxiong 30g, Radix Angelicae Dahuricae 50g, Cortex Cinnamomi 25g, Cortex Phellodendri 50g, Squama Manis 25g, Jing Jie fringe 25g, Radix Paeoniae Rubra 25g, Flos Lonicerae 50g, Ganoderma 15g, Oleum Sesami of Olibanum 10g;
Second step, Myrrha 35g, Fructus Crotonis 35g, Radix Curcumae 25g, Realgar 25g are made up, be mixed with a kind of yellow medicament with viscosity, throw on the plaster that posts at the above-mentioned steps stand;
In the 3rd step, hydrophite 25g, Borax 25g, hydrargrum oxydatum crudum 50g, Rhizoma Arisaematis 50g, Radix Aconiti Kusnezoffii 50g, Fructus Cnidii 25g, make a noise poplar bloassom 50g, Folium Artemisiae Argyi 50g carry out proportioning, throw on the xanchromatic medicament of second step.
Using method: directly spread on the affected part, 3 subsides are a course of treatment.
2, Drug therapy furuncle of the present invention, injure the clinical observation of plaster for rheumatic arthritis outward
1) physical data
Treat patient's 35 examples altogether, wherein male 20 examples, women 15 examples, the age was at 45~70 years old.Above-mentioned patient suffers from furuncle, hypertrophy or rheumatic arthritis all to some extent.
2) Therapeutic Method
Medicine of the present invention is a plaster, and cleaning directly applies behind the affected part.Paste every subsides 3-5 day a course of treatment 3
3) efficacy assessment standard
Produce effects: pain disappears, and skin ulcer cellulitis body, hypertrophy are eliminated or obviously dwindled, and be energetic, and stable disease is recovered work or physical labor normally.
Take a turn for the better: pain disappears, and skin ulcer cellulitis body, hypertrophy are obviously dwindled, spirit still can, Shi Youxiao still need treat repeatedly, treat 5 courses of treatment after, can recover normal.
Effectively: pain relief, spirit is recovered to some extent, and skin ulcer cellulitis body, hypertrophy are dwindled, and the state of an illness can be stablized a stage.
Invalid: symptom does not alleviate, and the state of an illness continues development.
4) therapeutic outcome (see the following form 1 and table 2)
Table 1 is observation of curative effect after treating
Table 2 sign after treating is improved situation
Symptom | Have an intense pain | Joint hyperplasia increases | Be off one's feed | Lassitude |
Before the treatment (example) | 23 | 25 | 30 | 35 |
Treatment back (example) | 2 | 1 | 1 | 0 |
Total effective rate (%) | 91% | 96% | 96.7% | 100% |
In a word, with the above-mentioned joint hyperplasia patient of Drug therapy of the present invention, produce effects 11 examples, 22 examples that take a turn for the better, invalid 0 example, obvious effective rate 31.4%, improvement rate 62.8%, effective percentage 94.3%, inefficiency 0.
Up to the present, concrete typical case used in the present invention has:
Case 1: temperature certain, the woman, 74 years old, rheumatic arthritis was suffered from one group in escarpment village, area just outside a city gate, Hua County, two lower limb aching and tired pain all day, arthroncus are met Changes in weather pain more very, go to too much tame hospital, have spent many medical care expensess.Through recommending use, after the course of treatment, arthroncus obviously changes, and pain obviously alleviates; Continuously reuse is after two courses of treatment, and two lower limb activities freely, pain disappears.
Case 2: Liu, the man, 75 years old, Weinan City railway lane through clapping the X-ray sheet, was diagnosed as knee hyperplasia, and both legs are unable on foot, and arthralgia must be as pinprick when walking, and pain makes that life is very inconvenient for many years.Through recommending to use medicine of the present invention, pain symptom disappears after five courses of treatment, and is very joyful.
Case 3: Guo, woman, 48 years old, agricultural machinery safety supervision station, Dali worker, because of being engaged in office work for a long time, frequent dizziness also has shoulder elbow pain, is diagnosed as hyperosteogeny after clapping the X-ray sheet, it is straight that the physiology curvature becomes, and the compressing arm goes various treatments back poor effect such as hospital massages, traction from nerve.Use this invention medicine after two courses of treatment after recommending, effect is very obvious, after adhere to three courses of treatment again, pain complete obiteration now, effect highly significant.
Claims (4)
1. treat furuncle, injure the plaster of rheumatic arthritis outward for one kind, it is characterized in that it is made up of following components in weight percentage: 8 parts of Crinis Carbonisatus, 3 parts of Radix Angelicae Sinensis, 3 parts in the Radix Rehmanniae, 1 part of Radix Et Rhizoma Rhei, 1 part of Radix Scutellariae, 1 part of the Radix Polygoni Multiflori, 1 part of Rhizoma Atractylodis, 2 parts of FANGQI, 3 parts of Rhizoma Chuanxiongs, 4 parts of the Radixs Angelicae Dahuricae, 2 parts of Cortex Cinnamomi, 4 parts of Cortex Phellodendris, 3 parts of Squama Manis, 3 parts of Jing Jie fringes, 2 parts of Radix Paeoniae Rubra, 4 parts of Flos Loniceraes, 2 parts of Ganodermas, 10 parts of Oleum Sesami of Olibanum.
2. treatment furuncle according to claim 1, injure the plaster of rheumatic arthritis outward, it is characterized in that 8 parts of Crinis Carbonisatus, 3 parts of Radix Angelicae Sinensis, 3 parts in the Radix Rehmanniae, 1 part of Radix Et Rhizoma Rhei, 1 part of Radix Scutellariae, 1 part of the Radix Polygoni Multiflori, 1 part of Rhizoma Atractylodis, 2 parts of FANGQI, 3 parts of Rhizoma Chuanxiongs, 4 parts of the Radixs Angelicae Dahuricae, 2 parts of Cortex Cinnamomi, 4 parts of Cortex Phellodendris, 3 parts of Squama Manis, 3 parts of Jing Jie fringes, 2 parts of Radix Paeoniae Rubra, 4 parts of Flos Loniceraes, 2 parts of Ganodermas, 10 parts of Oleum Sesami of Olibanum, 3 parts of Myrrhas, 3 parts of Fructus Crotonis, 3 parts of Radix Curcumaes, 3 parts of Realgar.
3. treatment furuncle according to claim 2, injure the plaster of rheumatic arthritis outward, it is characterized in that 8 parts of Crinis Carbonisatus, 3 parts of Radix Angelicae Sinensis, 3 parts in the Radix Rehmanniae, 1 part of Radix Et Rhizoma Rhei, 1 part of Radix Scutellariae, 1 part of the Radix Polygoni Multiflori, 1 part of Rhizoma Atractylodis, 2 parts of FANGQI, 3 parts of Rhizoma Chuanxiongs, 4 parts of the Radixs Angelicae Dahuricae, 2 parts of Cortex Cinnamomi, 4 parts of Cortex Phellodendris, 3 parts of Squama Manis, 3 parts of Jing Jie fringes, 2 parts of Radix Paeoniae Rubra, 4 parts of Flos Loniceraes, 2 parts of Ganodermas, 10 parts of Oleum Sesami of Olibanum, 3 parts of Myrrhas, 3 parts of Fructus Crotonis, 3 parts of Radix Curcumaes, 3 parts of Realgar, 4 parts of hydrophites, 4 parts of Borax, 4 parts of hydrargrum oxydatum crudums.
4. treatment furuncle according to claim 3, injure the plaster of rheumatic arthritis outward, it is characterized in that 8 parts of Crinis Carbonisatus, 3 parts of Radix Angelicae Sinensis, 3 parts in the Radix Rehmanniae, 1 part of Radix Et Rhizoma Rhei, 1 part of Radix Scutellariae, 1 part of the Radix Polygoni Multiflori, 1 part of Rhizoma Atractylodis, 2 parts of FANGQI, 3 parts of Rhizoma Chuanxiongs, 4 parts of the Radixs Angelicae Dahuricae, 2 parts of Cortex Cinnamomi, 4 parts of Cortex Phellodendris, 3 parts of Squama Manis, 3 parts of Jing Jie fringes, 2 parts of Radix Paeoniae Rubra, 4 parts of Flos Loniceraes, 2 parts of Ganodermas, 10 parts of Oleum Sesami of Olibanum, 3 parts of Myrrhas, 3 parts of Fructus Crotonis, 3 parts of Radix Curcumaes, 3 parts of Realgar, 4 parts of hydrophites, 4 parts of Borax, 4 parts of hydrargrum oxydatum crudums, 4 parts of Rhizoma Arisaematis, 4 parts of Radix Aconiti Kusnezoffii, 2 parts of Fructus Cnidiis, 4 parts of noisy poplar bloassoms, 4 parts of Folium Artemisiae Argyis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008102322023A CN101401873A (en) | 2008-11-11 | 2008-11-11 | Medicine plaster for treating furunculosis, exogenous injury and rheumatic arthritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008102322023A CN101401873A (en) | 2008-11-11 | 2008-11-11 | Medicine plaster for treating furunculosis, exogenous injury and rheumatic arthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101401873A true CN101401873A (en) | 2009-04-08 |
Family
ID=40536122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008102322023A Pending CN101401873A (en) | 2008-11-11 | 2008-11-11 | Medicine plaster for treating furunculosis, exogenous injury and rheumatic arthritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101401873A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518631B (en) * | 2009-04-12 | 2011-06-15 | 侯新华 | Medicament for treating rheumatoid arthritis |
CN102755503A (en) * | 2012-08-11 | 2012-10-31 | 杨献华 | Traditional Chinese medicine composition for treating skin trauma |
CN105194233A (en) * | 2015-09-26 | 2015-12-30 | 孙桂芝 | Treatment plaster for removing furuncle caused by yin fire |
CN109157625A (en) * | 2018-09-25 | 2019-01-08 | 安徽兆龙食品有限公司 | A kind of biological agent of high clarity and its application |
-
2008
- 2008-11-11 CN CNA2008102322023A patent/CN101401873A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518631B (en) * | 2009-04-12 | 2011-06-15 | 侯新华 | Medicament for treating rheumatoid arthritis |
CN102755503A (en) * | 2012-08-11 | 2012-10-31 | 杨献华 | Traditional Chinese medicine composition for treating skin trauma |
CN105194233A (en) * | 2015-09-26 | 2015-12-30 | 孙桂芝 | Treatment plaster for removing furuncle caused by yin fire |
CN109157625A (en) * | 2018-09-25 | 2019-01-08 | 安徽兆龙食品有限公司 | A kind of biological agent of high clarity and its application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101347536B (en) | External-use preparation for treating traumatic injury | |
CN101766773A (en) | Traditional Chinese medicine formula for treating heel pain | |
CN103191383B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
CN104189871A (en) | Medicated wine for treating osteoproliferation | |
CN103463241A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
CN102100754A (en) | Chinese medicinal composition for treating osteoproliferation | |
CN105560662A (en) | External-use traditional Chinese medicine composition for treating knee osteoarthritis | |
CN104771740A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
CN101401873A (en) | Medicine plaster for treating furunculosis, exogenous injury and rheumatic arthritis | |
CN103142938A (en) | Plaster for treating traumatic injury and fracture | |
CN103041261A (en) | Traditional Chinese medicine composition for treating heat type arthritis | |
CN101601767B (en) | Traditional Chinese medicine lotion for treating calcanodynia | |
CN103495126A (en) | Traditional Chinese medicine composition treating rheumatism | |
CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
CN103705671A (en) | Formula of traditional Chinese medicine for treating sciatica | |
CN102988833B (en) | Traditional Chinese medicine composition for treating rheumatism | |
CN102430084A (en) | Traditional Chinese medicine composition for treating arthralgia syndrome | |
CN102406870A (en) | Medicine for treating rheumatic arthralgia | |
CN105497779A (en) | Traditional Chinese medicine patch for treating acute lumbar sprain | |
CN105031447A (en) | Traditional Chinese medicine composition for treating bone fracture and preparation method thereof | |
CN104825617A (en) | Traditional Chinese medicine for treating rheumatism bone disease and traditional Chinese medicine bag | |
CN103893606B (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
CN103191305A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
CN105617214A (en) | Traditional Chinese medicine composition for treating scabies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20090408 |